Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To assess cardiac toxicity of anthracycline treatment with six biomarkers of cardiac injury: myoglobin, creatine kinase MB (CK-MB mass), cardiac troponin T (cTnT), cardiac troponin I (cTnI), heart-type fatty acid binding protein (H-FABP), glycogen phosphorylase BB (GPBB).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Exp. Oncol.

Title: Experimental oncology

Publisher:

ISSN: 1812-9269

ISSN (Print): 1812-9269

Publication date (Electronic): Jun 2008

Volume: 30

Issue: 2

Affiliations

[1 ] 2nd Department of Medicine-Clinical Hematology, University Hospital and Charles University, Faculty of Medicine in Hradec Kralove, Czech Republic. jan.hor@post.cz

Article

Publisher Item ID: 35/690

PubMed ID: 18566582

SO-VID: 88c3b2fc-ff7b-40d9-998d-5f3a4a8e6cbc

History

Data availability:

Comments

Comment on this article

Cited by 2

See all cited by